Acute intermittent porphyria

Clinical Research/Studies

Is there clinical research going on for acute intermittent porphyria?

There is a clinical trial for adeno-associated virus based gene therapy for acute intermittent porphyria (AIP) underway in Europe. This means that doctors are using a virus to deliver a working copy of the HMBS gene to the patient's body to replace the copy that is not working properly. Other than this, there are various other projects currently going on to look for treatments and triggers of AIP attacks.

To learn more about clinical trials, you can search this database.

Acute Intermittent Porphyria. Gene Reviews. (

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more about our use of cookies and similar technology

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me